Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
For patients with metastatic RCC and gross hematuria from the primary tumor, what palliative radiation regimen would you recommend to help control the bleeding?
In this example, the patient is unresponsive to primary therapy with on-goin hematuria.
Related Questions
How do you dose or sequence therapy to overcome radioresistance from oligometastatic disease from RCC?
Would you consider re-irradiation in the setting of prior salvage prostatectomy after prostate brachytherapy?
Are there studies looking at Ra-223 and SBRT for oligometastatic disease in the setting of mCRPC?
Should rectal spacing only be considered routinely for patients who are at elevated risk of rectal toxicity?
Are there reasons to not use prostate SBRT when treating the prostate +\- proximal SV?
Would you use neoadjuvant immunotherapy to spare renal cortex prior to SBRT?
Would you consider maintenance immunotherapy after cisplatin-gemcitabine chemotherapy and chemoRT for stage 3 bladder cancer in a patient declining cystectomy or who is a poor surgical candidate?
How would you manage a patient with a locally advanced bladder cancer s/p TURBT who had prior radiation?
How do you sequence Ra-223 and Lu-177 in patients with mCRPC with predominantly bony disease?
Would you treat a multifocal clear cell RCC in a solitary kidney with SBRT?